Clinical Trial Update: Clinical Trial to Evaluate the Efficacy of a Dyslipidemic Therapy in Mexican Population [Phase 3]

View source ↗

Summary

Phase 3 trial updating the efficacy of a dyslipidemic therapy in a Mexican population; status currently UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Dyslipidemias

Snippet

Sponsor: Laboratorios Grossman, S.A. | Conditions: Dyslipidemias, Cardiovascular Risk Factor | Phase 3 | Status: UNKNOWN